These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Angiogenesis research. Cancer drugs found to work in new way. Barinaga M Science; 2000 Apr; 288(5464):245. PubMed ID: 10777399 [No Abstract] [Full Text] [Related]
44. Setting up of an original computer-assisted methodology to characterize in vitro drug-induced anti-angiogenic effects. Farinelle S; Dehauwer C; Darro F; Decaestecker C; Fontaine J; Pasteels JL; Van Ham P; Atassi G; Kiss R Int J Mol Med; 1998 Nov; 2(5):545-53. PubMed ID: 9858650 [TBL] [Abstract][Full Text] [Related]
46. Antiangiogenic strategies in neuroblastoma. Ribatti D; Ponzoni M Cancer Treat Rev; 2005 Feb; 31(1):27-34. PubMed ID: 15707702 [TBL] [Abstract][Full Text] [Related]
47. A novel noninvasive model of endometriosis for monitoring the efficacy of antiangiogenic therapy. Becker CM; Wright RD; Satchi-Fainaro R; Funakoshi T; Folkman J; Kung AL; D'Amato RJ Am J Pathol; 2006 Jun; 168(6):2074-84. PubMed ID: 16723720 [TBL] [Abstract][Full Text] [Related]
48. Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases. Cao Y Nat Rev Drug Discov; 2010 Feb; 9(2):107-15. PubMed ID: 20118961 [TBL] [Abstract][Full Text] [Related]
50. Simulation of human B-lymphocyte proliferation by AGM-1470, a potent inhibitor of angiogenesis. Antoine N; Bours V; Heinen E; Simar LJ; Castronovo V J Natl Cancer Inst; 1995 Jan; 87(2):136-9. PubMed ID: 7535858 [No Abstract] [Full Text] [Related]
51. BAY 12-9566, a novel inhibitor of matrix metalloproteinases with antiangiogenic activity. Gatto C; Rieppi M; Borsotti P; Innocenti S; Ceruti R; Drudis T; Scanziani E; Casazza AM; Taraboletti G; Giavazzi R Clin Cancer Res; 1999 Nov; 5(11):3603-7. PubMed ID: 10589777 [TBL] [Abstract][Full Text] [Related]
52. Treatment of tamoxifen-refractory breast cancer--approach by animal models. Iino Y Breast Cancer; 2001; 8(4):262-4. PubMed ID: 11791115 [No Abstract] [Full Text] [Related]
53. The anti-angiogenic herbal extracts Ob-X from Morus alba, Melissa officinalis, and Artemisia capillaris suppresses adipogenesis in 3T3-L1 adipocytes. Hong Y; Kim MY; Yoon M Pharm Biol; 2011 Aug; 49(8):775-83. PubMed ID: 21449830 [TBL] [Abstract][Full Text] [Related]
55. Angiogenesis and surgery: from mice to man. Drixler TA; Voest EE; van Vroonhoven TJ; Borel Rinkes IH Eur J Surg; 2000 Jun; 166(6):435-46. PubMed ID: 10890539 [No Abstract] [Full Text] [Related]
56. Modulation of angiogenesis during adipose tissue development in murine models of obesity. Voros G; Maquoi E; Demeulemeester D; Clerx N; Collen D; Lijnen HR Endocrinology; 2005 Oct; 146(10):4545-54. PubMed ID: 16020476 [TBL] [Abstract][Full Text] [Related]
57. [Endostatin and angiostatin: two weapons, a single target]. Lopez M Clin Ter; 1998; 149(2):95-8. PubMed ID: 9780471 [No Abstract] [Full Text] [Related]
58. Assessment of the anti-obesity effects of the TNP-470 analog, CKD-732. Kim YM; An JJ; Jin YJ; Rhee Y; Cha BS; Lee HC; Lim SK J Mol Endocrinol; 2007 Apr; 38(4):455-65. PubMed ID: 17446235 [TBL] [Abstract][Full Text] [Related]
59. [Therapeutic prospects of angiogenesis inhibitors in cancerology]. Bout JC; Soncin F; Vandenbunder B Rev Mal Respir; 1999 Nov; 16(5):854-5. PubMed ID: 10612161 [No Abstract] [Full Text] [Related]
60. Effects of Korean red ginseng (Panax ginseng) on obesity and adipose inflammation in ovariectomized mice. Lee H; Choi J; Shin SS; Yoon M J Ethnopharmacol; 2016 Feb; 178():229-37. PubMed ID: 26707750 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]